In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug

References

• Sezgin-Bayindir Z, Yuksel N. Investigation of formulation variables and excipient interaction on the production of niosomes. Aaps Pharmscitech. 2012;13(3):826–835. doi:10.1208/s12249-012-9805-422644706
   PubMed Web of Science ®Google Scholar
• Shatalebi M, Mostafavi S, Moghaddas A. Niosome as a drug carrier for topical delivery of N-acetyl glucosamine. Res Pharm Sci. 2010;5(2):107.21589799
   PubMedGoogle Scholar
• Hamishehkar H, Rahimpour Y, Kouhsoltani M. Niosomes as a propitious carrier for topical drug delivery. Expert Opin Drug Deliv. 2013;10(2):261–272. doi:10.1517/17425247.2013.74631023252629
   PubMed Web of Science ®Google Scholar
• Calne R, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. 1978. J Am Society Nephrol. 1998;9(9):1751–1756.
   PubMedGoogle Scholar
• Tedesco D, Haragsim L. Cyclosporine: a review. J Transplant. 2012;2012. doi:10.1155/2012/230386
   PubMedGoogle Scholar
• Dehesa L, et al. The use of cyclosporine in dermatology. JDD. 2012;11(8):979–987.22859244
   PubMed Web of Science ®Google Scholar
• El-Ridy MS, et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm. 2011;37(12):1491–1508. doi:10.3109/03639045.2011.58743121707323
   PubMed Web of Science ®Google Scholar
• Kazi KM, et al. Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374. doi:10.4103/0110-5558.7643522247876
   PubMedGoogle Scholar
• Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105(1):1–6. doi:10.1016/0378-5173(94)90228-3
   Web of Science ®Google Scholar
• Bhaskaran S, Panigrahi L. Formulation and evaluation of niosomes using different non-ionic surfactants. Indian J Pharm Sci. 2002;64(1):63.
   Google Scholar
• Ravalika V, Sailaja A. Formulation and evaluation of etoricoxib niosomes by thin film hydration technique and ether injection method. Nano Biomed Eng. 2017;9(3):242–248. doi:10.5101/nbe.v9i3.p242-248
   Google Scholar
• Yeo L, et al. Brief effect of a small hydrophobic drug (cinnarizine) on the physicochemical characterisation of niosomes produced by thin-film hydration and microfluidic methods. Pharmaceutics. 2018;10(4):185. doi:10.3390/pharmaceutics10040185
   PubMed Web of Science ®Google Scholar
• Maruthapillai A, Palanisamy K, Sunkara M. Preparation and characterization of rilpivirine solid dispersions with the application of enhanced solubility and dissolution rate. Beni-Suef University J Basic Applied Sci. 2015;4(1):71–79. doi:10.1016/j.bjbas.2015.02.010
   Google Scholar
• Sezgin-Bayindir Z, Antep MN, Yuksel N. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug. AAPS PharmSciTech. 2015;16(1):108–117. doi:10.1208/s12249-014-0213-925204859
   PubMed Web of Science ®Google Scholar
• Khan MI, et al. Formulation design and characterization of a non-ionic surfactant based vesicular system for the sustained delivery of a new chondroprotective agent. Brazilian J Pharm Sci. 2015;51(3):607–615. doi:10.1590/S1984-82502015000300012
   Web of Science ®Google Scholar
• Bansal S, et al. Design and development of cefdinir niosomes for oral delivery. J Pharm Bioallied Sci. 2013;5(4):318. doi:10.4103/0975-7406.12008024302841
   PubMedGoogle Scholar
• Fay F, et al. SEM and EDX analysis: two powerful techniques for the study of antifouling paints. Progress Organic Coatings. 2005;54(3):216–223. doi:10.1016/j.porgcoat.2005.05.005
   Web of Science ®Google Scholar
• Pecchio M, et al. Development and validation of a HPLC method for the determination of cyclosporine a in new bioadhesive nanoparticles for oral Administration. Indian J Pharm Sci. 2014;76(2):132.24843186
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala S. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Scientific World J. 2014;2014.
   Google Scholar
• Aziz F, Gupta A, Khan M. Development and validation of a RP-HPLC method for determination of cyclosporine in capsule. Indian J Pharm Sci. 2010;72(2):252. doi:10.4103/0250-474X.6503020838535
   PubMed Web of Science ®Google Scholar
• Ceren Ertekin Z, Sezgin Bayindir Z, Yuksel N. Stability studies on piroxicam encapsulated niosomes. Curr Drug Deliv. 2015;12(2):192–199. doi:10.2174/156720181166614072311585225056419
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. Aaps Pharmscitech. 2010;11(3):1119–1127. doi:10.1208/s12249-010-9480-220635228
   PubMed Web of Science ®Google Scholar
• Wang K, et al. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Int J Nanomedicine. 2014;9:4991.25378925
   PubMed Web of Science ®Google Scholar
• Al-Meshal MA, et al. Oral administration of liposomes containing cyclosporine: a pharmacokinetic study. Int J Pharm. 1998;168(2):163–168. doi:10.1016/S0378-5173(98)00066-0
   Web of Science ®Google Scholar
• Campos S, et al. In vivo study of hepatic oxidative stress and mitochondrial function in rabbits with severe hypotension after propofol prolonged infusion. SpringerPlus. 2016;5(1):1349. doi:10.1186/s40064-016-2970-227588242
   PubMedGoogle Scholar
• Incecayir T. The effects of surfactants on the solubility and dissolution profiles of a poorly water-soluble basic drug, carvedilol. Die Pharmazie- Int J Pharm Sci. 2015;70(12):784–790.
   Google Scholar
• Zaki RM, et al. Formulation and in vitro evaluation of diacerein loaded niosomes. Int J Pharm Pharm Sci. 2014;6(Suppl 2):515–521.
   Google Scholar
• Jain S, Mittal A, Jain AK. Enhanced topical delivery of cyclosporin-A using PLGA nanoparticles as carrier. Curr Nanosci. 2011;7(4):524–530. doi:10.2174/157341311796196835
   Web of Science ®Google Scholar
• Deb TK, et al. In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets. Int J Pharm Investig. 2015;5(1):65. doi:10.4103/2230-973X.147236
   PubMedGoogle Scholar
• Lakshmana Prabu S, et al. Formulation and evaluation of sustained release microspheres of rosin containing aceclofenac. Ars Pharm 2009;50(2):1–12.
   Google Scholar
• Nowroozi F, et al. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iranian j Pharm Res. 2018;17(Suppl2):1.
   PubMed Web of Science ®Google Scholar
• Abhinav K, et al. Review on niosomes as novel drug delivery system. Int Res j Pharm. 2011;2(5):61–65.
   Google Scholar
• Chaw CS, Ah Kim KY. Effect of formulation compositions on niosomal preparations. Pharm Dev Technol. 2013;18(3):667–672. doi:10.3109/10837450.2012.67298822468904
   PubMed Web of Science ®Google Scholar
• Abdelkader H, et al. Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm. 2012;433(12):142–148. doi:10.1016/j.ijpharm.2012.05.01122595640
   PubMedGoogle Scholar
• Kumar S. Proniosomal gel of flurbiprofen: formulation and evaluation. J Drug Delivery Therapeutics. 2012;2:1. doi:10.22270/jddt.v2i1.31
   Google Scholar
• Khan MI, Madni A, Peltonen L. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. European J Pharm Sci. 2016;95(p):88–95. doi:10.1016/j.ejps.2016.09.00227600819
   PubMedGoogle Scholar
• Biswal S, et al. Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotechnol. 2008;1(1):1–8.
   Google Scholar
• Jin Y, et al. Development of a novel niosomal system for oral delivery of Ginkgo biloba extract. Int J Nanomedicine. 2013;8(p):421. doi:10.2147/IJN.S3798423378764
   PubMedGoogle Scholar
• Nadzir MM, et al. Size and stability of curcumin niosomes from combinations of Tween 80 and Span 80. Sains Malaysiana. 2017;46(12):2455–2460. doi:10.17576/jsm-2017-4612-22
   Web of Science ®Google Scholar
• Shilakari Asthana G, Sharma PK, Asthana A. In vitro and in vivo evaluation of niosomal formulation for controlled delivery of clarithromycin. Scientifica. 2016;2016.
   Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. European j Pharm Sci. 2001;13(2):123–133. doi:10.1016/S0928-0987(01)00095-111297896
   PubMed Web of Science ®Google Scholar
• Allam A, Fetih G. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate. Drug Des Devel Ther. 2016;10:2421. doi:10.2147/DDDT.S113775
   PubMed Web of Science ®Google Scholar
• Diva B, Ishwarya K, Naganjaneyulu R. In vitro drug release profile of aceclofenac niosomes formed with different ratios of cholestrol using sorbitan esters. Int J Chem Sci. 2014;12(1):237–247.
   Google Scholar
• Sambhakar S, Paliwal S, Sharma S, et al. Formulation of risperidone loaded proniosomes for effective transdermal delivery: an in-vitro and in-vivo study. Bulletin Faculty Pharm Cairo University. 2017;55(2):239–247. doi:10.1016/j.bfopcu.2017.09.003
   Google Scholar
• Aungst BJ. Intestinal permeation enhancers. J Pharm Sci. 2000;89(4):429–442. doi:10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J10737905
   PubMed Web of Science ®Google Scholar
• Arzani G, et al. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Int J Nanomedicine. 2015;10:4797.26251598
   PubMed Web of Science ®Google Scholar
• Jadon PS, et al. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech. 2009;10(4):1186. doi:10.1208/s12249-009-9325-z19856107
   PubMed Web of Science ®Google Scholar
• Roger E, et al. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine. 2010;5(2):287–306. doi:10.2217/nnm.09.11020148639
   PubMed Web of Science ®Google Scholar
• Gabrielsson J, Weiner D. Non-Compartmental Analysis, in Computational Toxicology. Springer 2012;377–389.
   Google Scholar